GMDx Genomics has developed a genomic Platform Technology that uses validated algorithms to provide a detailed analysis of an individual’s Innate Immune Fitness.
The analysis of an individual’s Innate Immune Fitness provides the diagnostic ability to predict an individual’s capability to mount an effective Adaptive Immune Response in a range of disease states.
GMDx analyses a Whole Genome Sequence (WGS) from any laboratory source and provides a comprehensive genomic profile on that individual that is in full compliance with all health information privacy regulations.
GMDx utilises an industry-leading framework developed by technology stack partners Applied Precision Medicine that is built on the Oracle Autonomous Cloud.
Company Details
- Employees
- 7
- Address
- 517 Flinders Ln, 201,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.gmdxgenomics.com
- Keywords
- Kuala Lumpur.
- HQ
- Melbourne CBD, Victoria
Gmdx Genomics Questions
Gmdx Genomics's website is https://www.gmdxgenomics.com
Gmdx Genomics's LinkedIn profile is https://au.linkedin.com/company/gmdx-genomics
Gmdx Genomics has
7 employees.
View email and phone details for 7
employees at Gmdx Genomics.
Gmdx Genomics's industry is
Biotechnology Research
Gmdx Genomics's top competitors are
Complii Fintech Solutions Ltd,
Studyum Foundation,
Primarymarkets,
Diamond Cut Leadership Network,
Kl Wellness City,
Ellechemy,
Biosignals Diagnostics,
Seera,
Commune Group,
Applied Precision Medicine Pty Ltd.
Gmdx Genomics's categories are Biotechnology Research
